Skip to main content
Clinical Trials/NCT07702318
NCT07702318Enrolling By InvitationNot Applicable

Early Childhood Neurodevelopmental, Economic and Nutritional Outcomes Among Former Very Low Birth Weight Infants From the Reducing Disparity in Mother's Own Milk (ReDiMOM) Trial

Rush University Medical Center1 site in 1 country275 target enrollmentStarted: September 23, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
275
Locations
1
Primary Endpoint
Cognition

Study Overview

Brief Summary

The goal of this study is to determine the long-term outcomes associated with an economic intervention that was provided to encourage mother's of very premature infants to provide mother's own milk. This study will follow children after they are discharged from the Neonatal Intensive Care Unit, where their mothers received the economic intervention, out to age 2 years. This study will examine childhood outcomes at 2 years of age based on which group the mothers had been randomized into. This study will also determine the relationship between the total duration mother's own milk was received during the first year of life and early childhood outcomes at age 2 years in infants that were born very premature.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 3 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Completion of the ReDiMOM RCT
  • survival of infant to NICU discharge

Exclusion Criteria

  • Mother has participated in this study with a previous pregnancy
  • infant is enrolled in another study that impacts neurodevelopment or adiposity
  • in the neonatologist's opinion the infant is unlikely to survive
  • the mother is unable or unwilling to provide consent

Arms & Interventions

ReDiMOM

Participants were enrolled in ReDiMOM RCT

Outcomes

Primary Outcomes

Cognition

Time Frame: 2 years

Cognitive index scores on Bayley Scales of Infant and Toddler Development-4th Edition at 20 months CA.

Total costs

Time Frame: 2 years

Total costs at 20 months CA will be determined from the societal perspective and defined as the sum of ReDiMOM intervention, healthcare, EI and associated family costs from birth to 20 months CA. Detailed intervention costs for each infant are already collected for the original ReDiMOM RCT. Healthcare costs will be obtained from 5 sources: 1) ReDiMOM RCT prospective database, 2) self-report questionnaire to assess family healthcare costs, 3) Medicaid claims, 4) Illinois State Early Intervention Database, and 5) RUMC system-wide cost-account and billing systems

Language

Time Frame: 2 years

Language index scores on Bayley Scales of Infant and Toddler Development-4th Edition at 20 months CA.

Motor

Time Frame: 2 years

Motor index scores on Bayley Scales of Infant and Toddler Development-4th Edition at 20 months CA.

MOM duration

Time Frame: 1 year

Duration of partial and/or exclusive MOM feedings through the first year of life using questionnaire.

Adiposity

Time Frame: 2 years

Adiposity measured by BIA

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
A study to find out the effectiveness of a 5-day training program for parents of children with neurodevelopmental disorders through pre and post-assessments.
CTRI/2025/09/095105Christian Medical College44
Recruiting
Not Applicable
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal DisordersNeurodevelopmental DisordersNeurodevelopmental Disorders (NDD)Neurodevelopmental Disorders and Developmental AbnormalitiesDevelopmental Delay (Disorder)Cerebral Palsy (CP)Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance ImpairmentCerebral Palsy InfantileCerebral Palsy Spastic HemiplegicCerebral Palsy, DyskineticAutism Spectrum Disorder (ASDHypoxic Ischemic EncephalopathyHypoxic Ischemic Encephalopathy (HIE)Traumatic Brain Injury (TBI)Sensory Processing DisorderChromosomal AbnormalitiesGenetic DisordersDown Syndrome (Trisomy 21)Fragile X Syndrome (FXS)RETT Syndrome With Proven MECP2 MutationWilliams Syndrome22q11.2 Deletion SyndromeSensorimotor IntegrationAutism Spectrum Disorder
NCT07493096Healing Hope International100
Unknown
Not Applicable
亲子互动促进家庭困境儿童大脑可塑性的神经机制及干预研究-干预部分非疾病人群
ChiCTR2600122548国家自然科学基金(编号:U23A20170)416
Not yet recruiting
Phase 3
Role of Panchendriyavardhana Ghrita Pratimarsha Nasya and Amalaki Avaleha orally in Indriyapradoshaja Vikaras or Sensory Processing Disorders in children with Autism.
CTRI/2025/07/090617Shruti K30
Not yet recruiting
Phase 3
NDT(Bo-bath) and customized functional mobility exercises for incomplete spinal cord injury management
CTRI/2024/03/064276Divya Khati30